Genscript Biotech's (HKG:1548) US-listed unit, Legend Biotech, expects a net loss of between around $94.7 million and $109.7 million for the six months ended June 30, a July 26 bourse filing said.
Shares of the biotechnology firm closed over 1% lower on Monday.
Price (HKD): $12.34, Change: $-0.14, Percent Change: -1.12%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments